MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
1.760
+0.020 (1.15%)
Apr 25, 2025, 4:00 PM EDT - Market closed
MDxHealth Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MDxHealth stock has a target of 6.00, which predicts an increase of 240.91% from the current stock price of 1.76.
Analyst Consensus: Buy
* Price targets were last updated on Nov 7, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for MDxHealth is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +240.91% | Nov 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +297.73% | Mar 7, 2024 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +354.55% | Mar 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +240.91% | Nov 9, 2023 |
| TD Cowen | TD Cowen | Buy Initiates $7 | Buy | Initiates | $7 | +297.73% | May 31, 2023 |
Financial Forecast
Revenue This Year
111.10M
from 90.05M
Increased by 23.38%
Revenue Next Year
129.81M
from 111.10M
Increased by 16.84%
EPS This Year
-0.40
from -1.16
EPS Next Year
-0.19
from -0.40
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 115.5M | 137.8M | 161.6M | |
| Avg | 111.1M | 129.8M | 157.0M | |
| Low | 105.9M | 122.5M | 150.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 28.3% | 24.0% | 24.5% | |
| Avg | 23.4% | 16.8% | 20.9% | |
| Low | 17.6% | 10.2% | 16.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.30 | -0.08 | 0.12 |
| Avg | -0.40 | -0.19 | 0.11 |
| Low | -0.47 | -0.33 | 0.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.